Added On : 24th October 2011Although IVIg is labeled pregnancy Category C, it is likely an excellent choice of therapy.
Pemphigus often affects women of child-bearing age. Treatment usually involves the use of powerful immunosuppressive drugs and high doses of systemic corticosteroids, such as prednisone. When a patient with pemphigus becomes pregnant or develops pemphigus during pregnancy, treatment becomes even more complicated. Intravenous immunoglobulin (IVIg) is an apparently good treatment option.
Added On : 15th December 2011Dermatopathology Workforce in the U.S.: An Overview
Who practices dermatopathology, how happy are they, and how can we assure a continuing presence at sufficiency in academia?
To characterize the dermatopathology workforce in the U.S., these authors sent a questionnaire to all 913 Fellow members of the American Society of Dermatopathology (ASDP). The objectives were to collect data about current practice and future plans, identify characteristics of academic practitioners, and explore satisfaction regarding fellowship training.
Added On : 28th December 2011Dr. Joel Gelfand elucidates the concept of number needed to screen in "Behind the Numbers", a new Journal Watch Dermatology feature aimed at clarifying issues in epidemiologic design and biostatistics.